Compass Therapeutics, Inc. (CMPX)
NASDAQ:CMPX
Want to see CMPX full AI Analyst Report?
Compass Therapeutics (CMPX) Ownership Overview
12.74% Insiders
7.10% Mutual Funds
67.57% Other Institutional Investors
10.48% ETFs
2.11% Public Companies and
Individual Investors
The ownership structure of Compass Therapeutics (CMPX) stock is a mix of institutional, retail, and individual investors. Approximately 85.15% of the company’s stock is owned by Institutional Investors, 12.74% is owned by Insiders, and 2.11% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $9828016 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $8568731 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $7132290 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $124585 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,219,994 | Insider | 8.45% | 30,744,388 | |
| 6,982,536 | Institution | 3.88% | 14,104,723 | |
| 6,603,336 | Insider | 3.67% | 13,338,739 | |
| 5,901,798 | Institution | 3.28% | 11,921,632 | |
| 4,808,917 | Institution | 2.67% | 9,714,012 | |
| 4,325,370 | Institution | 2.40% | 8,737,247 | |
| 3,606,000 | Institution | 2.00% | 7,284,120 | |
| 1,857,848 | Institution | 1.03% | 3,752,853 | |
| 1,619,798 | Institution | 0.90% | 3,271,992 | |
| 1,541,367 | Institution | 0.86% | 3,113,561 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,901,798 | Institution | 3.28% | 11,921,632 | |
| 1,541,367 | Institution | 0.86% | 3,113,561 | |
| 1,415,514 | Institution | 0.79% | 2,859,338 | |
| 768,054 | Institution | 0.43% | 1,551,469 | |
| 646,144 | Institution | 0.36% | 1,305,211 | |
| 521,060 | Institution | 0.29% | 1,052,541 | |
| 417,170 | Institution | 0.23% | 842,683 | |
| 345,308 | Institution | 0.19% | 697,522 | |
| 211,802 | Institution | 0.12% | 427,840 | |
| 151,722 | Institution | 0.08% | 306,478 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,190,854 | Institution | 2.33% | 9,974,233 | |
| 4,080,809 | Institution | 2.27% | 8,365,658 | |
| 2,997,611 | Institution | 1.66% | 6,055,174 | |
| 1,714,586 | Institution | 0.95% | 4,080,715 | |
| 685,638 | Institution | 0.38% | 1,405,558 | |
| 664,018 | Institution | 0.37% | 1,580,363 | |
| 572,487 | Institution | 0.32% | 1,156,424 | |
| 524,020 | Institution | 0.29% | 1,058,520 | |
| 481,828 | Institution | 0.27% | 973,293 | |
| 335,050 | Institution | 0.19% | 676,801 |
FAQ
Who Owns Compass Therapeutics, Inc. (CMPX)?
According to the latest TipRanks data, approximately 67.57% of the company's stock is held by institutional investors, 12.74% is held by insiders, and 2.11% is held by retail investors.
What percentage of Compass Therapeutics, Inc. (CMPX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 67.57% of Compass Therapeutics, Inc. (CMPX) stock is held by institutional investors.
What percentage of Compass Therapeutics, Inc. (CMPX) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.11% of Compass Therapeutics, Inc. (CMPX) stock is held by retail investors.
Who owns the most shares of Compass Therapeutics, Inc. (CMPX)?
Carl Gordon owns the most shares of Compass Therapeutics, Inc. (CMPX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.